...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Critical care : >Epinephrine for prehospital cardiac arrest with non-shockable rhythm
【24h】

Epinephrine for prehospital cardiac arrest with non-shockable rhythm

机译：肾上腺素用于院前心脏骤停且不可电击的心律

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cardiopulmonary arrest research and guidelines have generally focused on the treatment and management of ventricular fibrillation and pulseless ventricular fibrillation (electrical shockable rhythms). Less investigation has been done on the subpopulation of cardiopulmonary arrest victims that present with non-shockable rhythms. In a new paper, Goto, Maeda, and Goto present evidence that early use of epinephrine for treatment is associated with better survival with functional outcome. While there is a lack of evidence to support epinephrine for management of cardiopulmonary arrest presenting with initial shockable rhythms (presumed primary cardiac origin), there is now evidence that epinephrine may potentially benefit those presenting with non-shockable cardiopulmonary arrest (presumed heterogeneous origins). Further research on non-shockable rhythm cardiopulmonary arrest is needed to understand the subpopulation and develop better treatment guidelines.
机译：心肺骤停的研究和指南通常侧重于心室纤颤和无脉性心室纤颤（电击性心律）的治疗和管理。对心律不齐的心肺骤停患者亚群的研究较少。 Goto，Maeda和Goto在一篇新论文中提供了证据，表明早期使用肾上腺素治疗可以改善患者的功能预后。尽管目前尚无证据支持肾上腺素用于治疗以最初的可电击性节律（假定为主要心脏起源）表现的心肺骤停，但现在有证据表明肾上腺素可能有益于表现为不可电击的心肺骤停（假定为异源起源）的患者。需要进一步研究不可电击的心律失常，以了解亚群并制定更好的治疗指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号